Nepafenac: all 46 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract SurgeryRecruitingNCT07178639Not applicable
• Clinical Endpoint Study of Nepafenac 0.3% Opthalmic SuspensionCompletedNCT03499873Phase 3Results posted
• Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus PlaceboCompletedNCT03025945Not applicableResults posted
• Dropless vs. Standard Drops Contralateral Eye StudyCompletedNCT02515045Phase 4Results posted
• Nepafenac Once Daily for Macular Edema - Study 1CompletedNCT01853072Phase 3Results posted
• NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)CompletedNCT01331005Phase 2Results posted
• Nepafenac 0.3% Two StudyCompletedNCT01318499Phase 2Results posted
• Confirmatory Study Nepafenac 0.3%CompletedNCT01109173Phase 3Results posted
• A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing PhacoemulsificationCompletedNCT01021761Phase 4Results posted
• A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing PhacoemulsificationCompletedNCT01001806Phase 4Results posted
• A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy PatientsCompletedNCT00782717Phase 2Results posted
• Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract SurgeryCompletedNCT00494494Phase 4Results posted
• Comparison Between Low-Dose and High-Dose Nepafenac SodiumCompletedNCT07749027Not applicable
• Perioperative Topical Nepafenac After Epiretinal Membrane SurgeryCompletedNCT07736690Phase 4
• Efficacy of Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Cystoid Macular Edema Following Cataract PhacoemulsificationCompletedNCT07696104Phase 4
• A Comparative Analysis of the Effectiveness of Nepafenac Combined With a Lubricant Versus a Lubricant Alone in the Treatment of Epiphora Associated With Lacrimal Punctum StenosisActive, not recruitingNCT07372014Phase 4
• Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative VitreoretinopathyCompletedNCT07162818Phase 4
• CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye DropsStatus unknownNCT04843839Phase 2
• Post Intravitreal Injection Topical NSAID vs. PatchingStatus unknownNCT03918590Phase 4
• Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical TrialCompletedNCT03886779Phase 4
• PGE2 Levels in Patient Treated With NSAIDsCompletedNCT03597867Phase 3
• Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal InjectionsCompletedNCT03406689Not applicable
• Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral IridotomyStatus unknownNCT02955641Not applicable
• Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal InjectionsCompletedNCT02821390Not applicable
• Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%CompletedNCT02752646Not applicable
• Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient ComfortStatus unknownNCT02506348Not applicable
• Topical Nepafenac as Supplement for Diabetic Macular EdemaCompletedNCT02443012Phase 4
• NSAIDs and PGE2 Levels in Vitrectomy PatientsCompletedNCT02361645Phase 3
• Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After PhacoemulsificationCompletedNCT02084576Phase 4
• Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal EyesCompletedNCT01995890Phase 4
• Macular Edema Nepafenac vs. Difluprednate Uveitis TrialTerminatedNCT01939691Phase 4
• Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract SurgeryCompletedNCT01395069Phase 4
• Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial ConjunctivitisWithdrawnNCT01238783Phase 2
• Macular Edema Incidence/Severity Reduction With NevanacTerminatedNCT00939276Phase 3
• Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular EdemaCompletedNCT00900887Phase 2
• Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)Status unknownNCT00869219Phase 4
• Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in FacetectomiesStatus unknownNCT00865540Phase 4
• Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)CompletedNCT00828477Phase 4
• Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane SurgeryCompletedNCT00818844Phase 4
• Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal PhotocoagulationTerminatedNCT00801905Phase 2
• Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular EdemaCompletedNCT00780780Phase 3
• Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and PlaceboCompletedNCT00405730Phase 3
• Acular LS vs. Nevanac in Post op Inflammation Following Cataract SurgeryCompletedNCT00348582Phase 4
• Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRKCompletedNCT00347204Phase 4
• Nevanac 3-Month Safety Study With QID DosingCompletedNCT00332774Phase 3
• A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain ReliefCompletedNCT00330798Phase 4

← Nepafenac overview